NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/15/2024
Back to search
Official data from USPTO
WOMEN IN PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WOMEN IN PHARMA
ST13
US500000087476810Class
36, 41
Filing
87476810
Registration
5326281
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
07/15/2024
Trademark type
Word
Nice classes
36, 41
Filing date
06/06/2017
Registration date
10/31/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/15/2024
Last transaction
07/15/2024
Responsible office
United States Patent and Trademark Office
Status code
704
Official register
Supplemental Register
First use anywhere
2016-09-00
First use in commerce
2016-09-00
Drawing code
4
Owner type
03
Owner location
Tampa, FL
Examiner
CORDOVA, RAUL
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
International Society for Pharmaceutical Engineering, Inc.
International Society for Pharmaceutical Engineering, Inc.
Representatives
David M. Abrahams Webster, Chamberlain & Bean, LLP
Technical classification
Nice Classes
Class 36Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 36
Providing scholarships to support and inspire women in the pharmaceutical industry at various stages of their careers
Class 41
Educational servicesarranging and conducting roundtable and panel discussions on the challenges and opportunities of female professionals in the pharmaceutical industry
Publications
History of USPTO decisions and trademark events.
27 publications found
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
07/15/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/09/2024
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
01/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/12/2024
ES8R
TEAS SECTION 8 RECEIVED
10/30/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/31/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/13/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/13/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2019
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2019
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
10/31/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/26/2017
ALIE
ASSIGNED TO LIE
09/25/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
09/18/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/11/2017
ALIE
ASSIGNED TO LIE
09/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/11/2017
DOCK
ASSIGNED TO EXAMINER
09/06/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/13/2017
NWAP
NEW APPLICATION ENTERED
06/09/2017
Continuous trademark protection
Get notified about every new filing that threatens WOMEN IN PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.